Nebraska Hematology-Oncology, PC — Lincoln, Nebraska

Nebraska Hematology-Oncology, PC is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Hematology-Oncology, PC has participated in 7 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Sponsors: CTI BioPharma, Novacea, Northwestern University.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology-Oncology, PC?

Nebraska Hematology-Oncology, PC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology-Oncology, PC conducted?

Nebraska Hematology-Oncology, PC has 7 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Is Nebraska Hematology-Oncology, PC accredited by Crixeo Health?

Nebraska Hematology-Oncology, PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Hematology-Oncology, PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.